BioAtla, Inc.

📍 San Diego, United States🗓 Founded 2007👥 62 employees💰 Last funded Apr 2019
Biotechnology Research🌐 BioAtla.com
Website LinkedIn
BioAtla is a protein therapeutic company that uses discovery and evolution to develop safer and more potent drugs for the treatment of cancer. The culmination of our discovery and evolution expertise and more than 150 issued patents and patent applications is our Conditionally Active Biologics (CAB) platform, whereby monoclonal antibodies or other biologics can be engineered for selective conditional activation, for example preferential binding under the unique conditions of the tumor microenvironment. This improvement in tumor selectivity helps address the issue of on-target toxicity and improve therapeutic index. BioAtla is applying these technologies in our own pipeline and in partnerships to ultimately deliver better immunotherapies for cancer.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2007
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BioAtla, Inc.?
BioAtla, Inc. has 1 investors on record on gritt.io.
When did BioAtla, Inc. last raise funding?
The most recent investment in BioAtla, Inc. recorded on gritt.io was in April 2019.
When was BioAtla, Inc. founded?
BioAtla, Inc. was founded in 2007.
What industry is BioAtla, Inc. in?
BioAtla, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioAtla, Inc. based?
BioAtla, Inc. is headquartered in San Diego, United States.